Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 5/2018

01-05-2018 | Original Article

Improved quality of care for patients infected or colonised with ESBL-producing Enterobacteriaceae in a French teaching hospital: impact of an interventional prospective study and development of specific tools

Authors: Véronique Mondain, Florence Lieutier, Céline Pulcini, Nicolas Degand, Luce Landraud, Raymond Ruimy, Thierry Fosse, Pierre Marie Roger

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 5/2018

Login to get access

Abstract

The increasing incidence of ESBL-producing Enterobacteriaceae (ESBL-E) in France prompted the publication of national recommendations in 2010. Based on these, we developed a toolkit and a warning system to optimise management of ESBL-E infected or colonised patients in both community and hospital settings. The impact of this initiative on quality of care was assessed in a teaching hospital. The ESBL toolkit was developed in 2011 during multidisciplinary meetings involving a regional network of hospital, private clinic and laboratory staff in Southeastern France. It includes antibiotic treatment protocols, a check list, mail templates and a patient information sheet focusing on infection control. Upon identification of ESBL-E, the warning system involves alerting the attending physician and the infectious disease (ID) advisor, with immediate, advice-based implementation of the toolkit. The procedure and toolkit were tested in our teaching hospital. Patient management was compared before and after implementation of the toolkit over two 3-month periods (July–October 2010 and 2012). Implementation of the ESBL-E warning system and ESBL-E toolkit was tested for 87 patients in 2010 and 92 patients in 2012, resulting in improved patient management: expert advice sought and followed (16 vs 97%), information provided to the patient’s general practitioner (18 vs 63%) and coding of the condition in the patient’s medical file (17 vs 59%), respectively. Our multidisciplinary strategy improved quality of care for in-patients infected or colonised with ESBL-E, increasing compliance with national recommendations.
Literature
4.
8.
go back to reference Ho C, Lau A, Cimon K, Farrah K, Gardam M (2012) Screening, isolation, and decolonization strategies for vancomycin-resistant enterococci or extended spectrum beta-lactamase producing organisms: a systematic review of the clinical evidence and health services impact [Internet]. Canadian Agency for Drugs and Technologies in Health, Ottawa (ON) CADTH Rapid Response Reports Ho C, Lau A, Cimon K, Farrah K, Gardam M (2012) Screening, isolation, and decolonization strategies for vancomycin-resistant enterococci or extended spectrum beta-lactamase producing organisms: a systematic review of the clinical evidence and health services impact [Internet]. Canadian Agency for Drugs and Technologies in Health, Ottawa (ON) CADTH Rapid Response Reports
10.
go back to reference Arnaud I, Maugat S, Jarlier V, Astagneau P (2015) National Early Warning; Investigation and Surveillance of Healthcare-Associated Infections Network (RAISIN)/multidrug resistance study group. Ongoing increasing temporal and geographical trends of the incidence of extended-spectrum beta-lactamase-producing Enterobacteriaceae infections in France, 2009 to 2013. Euro Surveill 20(36). https://doi.org/10.2807/1560-7917.ES.2015.20.36.30014. Arnaud I, Maugat S, Jarlier V, Astagneau P (2015) National Early Warning; Investigation and Surveillance of Healthcare-Associated Infections Network (RAISIN)/multidrug resistance study group. Ongoing increasing temporal and geographical trends of the incidence of extended-spectrum beta-lactamase-producing Enterobacteriaceae infections in France, 2009 to 2013. Euro Surveill 20(36). https://​doi.​org/​10.​2807/​1560-7917.​ES.​2015.​20.​36.​30014.​
11.
go back to reference De Angelis G, Cataldo MA, De Waure C, Venturiello S, La Torre G, Cauda R, Carmeli Y, Tacconelli E (2014) Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis. J Antimicrob Chemother 69(5):1185–1192. https://doi.org/10.1093/jac/dkt525 CrossRefPubMed De Angelis G, Cataldo MA, De Waure C, Venturiello S, La Torre G, Cauda R, Carmeli Y, Tacconelli E (2014) Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis. J Antimicrob Chemother 69(5):1185–1192. https://​doi.​org/​10.​1093/​jac/​dkt525 CrossRefPubMed
12.
go back to reference Kac G, Grohs P, Durieux P, Trinquart L, Gueneret M, Rodi A, Boiron P, Guillemain R, Leglise J, Meyer G (2007) Impact of electronic alerts on isolation precautions for patients with multidrug-resistant bacteria. Arch Intern Med 167(19):2086–2090CrossRefPubMed Kac G, Grohs P, Durieux P, Trinquart L, Gueneret M, Rodi A, Boiron P, Guillemain R, Leglise J, Meyer G (2007) Impact of electronic alerts on isolation precautions for patients with multidrug-resistant bacteria. Arch Intern Med 167(19):2086–2090CrossRefPubMed
Metadata
Title
Improved quality of care for patients infected or colonised with ESBL-producing Enterobacteriaceae in a French teaching hospital: impact of an interventional prospective study and development of specific tools
Authors
Véronique Mondain
Florence Lieutier
Céline Pulcini
Nicolas Degand
Luce Landraud
Raymond Ruimy
Thierry Fosse
Pierre Marie Roger
Publication date
01-05-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 5/2018
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3234-6

Other articles of this Issue 5/2018

European Journal of Clinical Microbiology & Infectious Diseases 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.